GALECTIN THERAPEUTICS INC. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- GALECTIN THERAPEUTICS INC. stock issued during period, shares, new issues for fiscal 2016 was 2.81M shares.
- GALECTIN THERAPEUTICS INC. stock issued during period, shares, new issues for fiscal 2015 was 4.76M shares.
- GALECTIN THERAPEUTICS INC. stock issued during period, shares, new issues for fiscal 2002 was 537.23K shares, a 367.63% increase from fiscal 2001.
- GALECTIN THERAPEUTICS INC. stock issued during period, shares, new issues for fiscal 2001 was 114.88K shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2016-12-31 | 2.81M shares 10-K · filed 2017-03-28 | |
| 2015-11-25 | 4.76M shares 10-K · filed 2017-03-28 | |
| 2002-12-31 | 537.23K shares 10-K · filed 2014-03-21 | |
| 2001-12-31 | 114.88K shares 10-K · filed 2014-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |